Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Search Inside the pdf :

Gennex Laboratories Ltd.

14 Nov 2025, 05:29PM

15.76

0.57%

Result

Gennex Laboratories Ltd - 531739 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

In just concluded meeting of Board of Directors , the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the quarter and half year ended September 30, 2025; 2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2025; 3. Other Business We hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 5.00 PM. This information is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	39.30	36.45	33.38	7.8%	17.7%
Operating Profit Qtr	5.50	5.07	5.62	8.5%	-2.1%
Net Profit Qtr	9.62	5.02	4.83	91.6%	99.2%
Earning Per Share Adjusted latest Qtr	0.40	0.21	0.20	90.5%	100.0%

* Consolidated data

Detailed Results

Gennex Laboratories Ltd.

14 Nov 2025, 05:14PM

15.76

0.57%

Board Meeting

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Unaudited Financial Results For The Quarter …

BSE India

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2025 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2025 (annexed here with); 3. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 5:00 PM. This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

06 Nov 2025

15.76

0.57%

Company Update

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday, November 14, 2025 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2025 along with the Limited Review Report of the Statutory Auditors of the Company. Notice had been published in both Business Standard and Saksham (Local-Telugu) on November 05, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

04 Nov 2025

15.76

0.57%

Board Meeting

Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial …

BSE India

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2025; 2. Consider the Limited Review Reports'' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2025; 3. Other Business items.

pdf

Gennex Laboratories Ltd.

13 Oct 2025, 04:59PM

15.76

0.57%

Company Update

Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from M/s R&D Infotech Private Limited, Registrar and Transfer Agent of the Company for the Quarter ended September 30, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

01 Oct 2025

15.76

0.57%

AGM

Gennex Laboratories Ltd - 531739 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 40th electroic Annual General Meeting of the Company held on September 30, 2025 at 12.30 Hrs through Video Conferencing and Other Audio Visual Means along with the Consolidated Scrutinizers Report. It is to inform that all resolutions set out in the Notice of the 40th eAGM were duly approved by shareholders with requisite majority. The vosting results along with the Scrutinizers report is also being enclosed in this letter and uploaded on the website of the Company i.e., www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

30 Sep 2025

15.76

0.57%

AGM

Gennex Laboratories Ltd - 531739 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 40th AGM of the Company held on Tuesday, September 30, 2025 through Video Conferencing / other audio visual means. The meeting was held in compliance to the General Circular No. 09/2024 of September 19, 2024 issued by MCA and Circular No. 2024/133 dated October 03, 2024 issued by SEBI, companies are allowed to hold AGM through VC / OAVM without the physical presence of the members at a common venue till September 30, 2025 and other applicable provisions of the Companies Act, 2013 read with rules made thereunder. The meeting commenced at 12.30 Hrs and concluded at 13.11 Hrs. All the requisite Statutory Registers and other documents were available electronically during the AGM for inspection by the members. This intimation is also uploaded in the Company website: www.gennexlab.com. We request you to take above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

23 Sep 2025

15.76

0.57%

SAST

Gennex Laboratories Ltd - 531739 - Closure of Trading Window

BSE India

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s code of conduct for regulating, monitoring and reporting of Trading by insiders, the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2025 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2025 along with other matters for which trading window is required to be closed. The Board Meeting date to approve the Un-audited Standalone and Consolidated Financial results for the second quarter and half year ended September 30, 2025 will be informed in due course. All Promoters/ designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.

pdf

Gennex Laboratories Ltd.

08 Sep 2025

15.76

0.57%

Company Update

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find herewith Newspaper publication of AGM Notice and e-Voting related instructions advertisement published in Business Standard and Saksham (Local) on September 06, 2025 for the 40th Annual General Meeting of the Company to be held on September 30, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

08 Sep 2025

15.76

0.57%

Corp. Note

Gennex Laboratories Ltd - 531739 - Reg. 34 (1) Annual Report.

BSE India

With reference to the subject matter, As per the Regulation 34 of SEBI (LODR) Regulations, 2015, we hereby submits 40th Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31, 2025, inter alia, Notice of the Annual General Meeting to be held on Tuesday, September 30, 2025, Director''s Report, Independent Audit Report of. Statutory Auditor, Financial Statements (Standalone and Consolidated), being Balance Sheet, Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31, 2025 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours. This intimation is also being uploaded on the Company website: www.gennexlab.com.

pdf

Is Gennex Laboratories Ltd. worth buying?

129 Votes:

Buy 83.72%

Sell 6.2%

Hold 10.08%